Sachetta’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Sachetta’s Portfolio NARI Stock Details NARI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-13	Closed	-$844	–	1310
2024 Q1	$844	Hold	13	–	–	﹤0.01%	953
2023 Q4	$844	Buy	+13	New	+$783	﹤0.01%	953

Other funds holding NARI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HCC Manager Chicago, Illinois $10.3M AUM 6.8% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sachetta's NARI Position: Q2 2024 in Review

Sachetta sold out of Inari Medical, Inc. Common Stock (NARI) in Q2 2024, closing a stake of 13 shares — an estimated $844 sold.

Sachetta first reported a position in NARI in Q4 2023 and held it in 2 quarters. The position peaked at $844 in Q1 2024. 243 funds tracked by Wall St. Rank hold NARI as of Q2 2024.

Sachetta reported no remaining Inari Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Sachetta sold 13 Inari Medical, Inc. Common Stock shares in Q2 2024, an estimated $844.
Sachetta first reported a position in Inari Medical, Inc. Common Stock in Q4 2023 and held it in 2 quarters.
Sachetta's Inari Medical, Inc. Common Stock position peaked at $844 in Q1 2024.
243 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q2 2024.

Based on Sachetta's 13F filing for Q2 2024, filed 7 Aug 2024.